APREA THERAPEUTICS, INC. (APRE) Social Stream



APREA THERAPEUTICS, INC. (APRE): $4.44

-0.16 (-3.48%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add APRE to Watchlist
Sign Up

Industry: Biotech


Ranked

of 405

in industry

APREA THERAPEUTICS INC (APRE) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering APREA THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 3 $5 $4 $4.5 $4.55 -1.1%
2022-03-16 2 $5 $2 $3.5 $4.55 -23.08%
2022-07-08 3 $5 $2 $3.333 $4.55 -26.75%
2022-08-15 3 $3 $2 $2.5 $4.55 -45.05%
2022-11-10 3 $60 $60 $60 $4.55 1218.68%
2023-03-17 3 $60 $16 $45.333 $4.55 896.33%

The Trend in the Analyst Price Target


APRE's average price target has moved up $38.08 over the prior 22 months.

APRE reports an average of 2,055.01% for its upside potential over the past 36 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2022-07-08 3 5 2 3.333 0.950 250.84%
2022-08-15 2 3 2 2.500 0.920 171.74%
2022-08-15 3 3 2 2.500 0.920 171.74%
2022-11-10 3 3 3 3.000 0.525 471.43%
2023-03-10 3 60 16 45.333 5.040 799.46%

APRE Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1 3 0 0 0 0 3

The Trend in the Broker Recommendations


Over the past 17 months, APRE's average broker recommendation rating improved by 2.4.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • To contextualize these metrics, consider that out of all US stocks, APREA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 322.7% of them.
  • APREA THERAPEUTICS INC's average analyst price target is higher than 316.44% of stocks in the small market cap category.
  • In terms of how APREA THERAPEUTICS INC fares relative to Healthcare stocks, note that its number of analysts covering the stock is greater than 122.64% of that group.
  • In terms of how APREA THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its variance in analysts' estimates is lower than -262.74% of that group.

In the Pharmaceutical Products industry, FREQ, STSA, and MIRM are the three stocks most similar to APREA THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

Is APRE a Buy, Hold or Sell? See the POWR Ratings now!


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.7496 seconds.